Pathophysiology of thalassemia

SL Schrier - Current opinion in hematology, 2002 - journals.lww.com
SL Schrier
Current opinion in hematology, 2002journals.lww.com
Despite discoveries concerning the molecular abnormalities that led to the thalassemic
syndromes, it still is not known how accumulation of excess unmatched α-globin in β
thalassemia and β-globin in α thalassemia leads to red blood cell hemolysis in the
peripheral blood, and in the β thalassemias particularly, premature destruction of erythroid
precursors in marrow (ineffective erythropoiesis). Oxidant injury may cause hemolysis, but
there is no evidence that it causes ineffective erythropoiesis. Hemoglobin E/β thalassemia is …
Abstract
Despite discoveries concerning the molecular abnormalities that led to the thalassemic syndromes, it still is not known how accumulation of excess unmatched α-globin in β thalassemia and β-globin in α thalassemia leads to red blood cell hemolysis in the peripheral blood, and in the β thalassemias particularly, premature destruction of erythroid precursors in marrow (ineffective erythropoiesis). Oxidant injury may cause hemolysis, but there is no evidence that it causes ineffective erythropoiesis. Hemoglobin E/β thalassemia is now a worldwide clinical problem. The reasons underlying the heterogeneity and occasional severity of the syndrome remain obscure. Ineffective erythropoiesis now appears to be caused by accelerated apoptosis, in turn caused primarily by deposition of α-globin chains in erythroid precursors. However, it is not clear how α-globin deposition causes apoptosis. The author uses new observations on the control of erythropoiesis to provide a framework for studying the enhanced thalassemic erythroid apoptosis.
Lippincott Williams & Wilkins